Why is Clinitech Lab falling/rising?

As of 17-Sep, Clinitech Laboratory Ltd is currently priced at 46.04, with no change in price (0.00%). The stock has experienced erratic trading, having not traded on one day out of the last twenty days. Its performance today is inline with the sector, but it is noteworthy that the stock's delivery volume has fallen significantly by 47.37% against the 5-day average, indicating a decline in investor participation. Over the past week, the stock has dropped by 9.73%, while it has shown a modest increase of 4.64% over the past month. However, year-to-date, the stock has declined by 41.62%, which is a concerning trend compared to the Sensex's 5.83% increase.
In the broader market context, Clinitech's short-term performance has been significantly worse than the benchmark, as evidenced by its 1-week decline of 9.73% compared to the Sensex's gain of 1.56%. This stark contrast highlights the stock's underperformance relative to the market. Additionally, the stock's moving averages indicate that it is currently lower than the 5-day, 20-day, 100-day, and 200-day moving averages, suggesting a bearish trend. The lack of available positive or negative factors further complicates the outlook, as there are no specific catalysts identified that could influence a turnaround in the stock's performance.